(NASDAQ: FBIO) Fortress Biotech's forecast annual revenue growth rate of 50.61% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Fortress Biotech's revenue in 2025 is $57,784,000.On average, 1 Wall Street analysts forecast FBIO's revenue for 2025 to be $3,048,363,053, with the lowest FBIO revenue forecast at $3,048,363,053, and the highest FBIO revenue forecast at $3,048,363,053. On average, 1 Wall Street analysts forecast FBIO's revenue for 2026 to be $4,339,977,158, with the lowest FBIO revenue forecast at $4,339,977,158, and the highest FBIO revenue forecast at $4,339,977,158.
In 2027, FBIO is forecast to generate $5,878,500,096 in revenue, with the lowest revenue forecast at $5,878,500,096 and the highest revenue forecast at $5,878,500,096.